Other respiratory viruses are important contributors to adult respiratory hospitalizations and mortality even during peak weeks of the influenza season

Open Forum Infectious Diseases

Volumn 1, Issue 2, 2014, Pages

  Gilca, Rodica ^a,b,c   Amini, Rachid ^a   Douville Fradet, Monique ^a   Charest, Hugues ^a   Dubuque, Josée ^d   Boulianne, Nicole ^a,b   Skowronski, Danuta M ^e   Serres, Gaston De ^a,b,c  

^a INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d Ministere de la Sante et des Services Sociaux   (Canada)

^e BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

Adults; Elderly; Hospitalization; Influenza; Mortality; Respiratory viruses

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; INFLUENZA VACCINE;

ADENOVIRIDAE; ADULT; AGED; ARTICLE; CORONAVIRIDAE; COUGHING; DISEASE SEVERITY; ENTEROVIRUS; FEMALE; FEVER; HEALTHCARE ASSOCIATED INFECTION; HOSPITALIZATION; HUMAN; HUMAN BOCAVIRUS; HUMAN METAPNEUMOVIRUS; INFLUENZA; INFLUENZA A; INFLUENZA B; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; NONHUMAN; NOSE SMEAR; PARAMYXOVIRINAE; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY VIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHINOVIRUS; SORE THROAT; VIRAL RESPIRATORY TRACT INFECTION;

EID: 84941307421     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofu086     Document Type: Article

References (40)

1. ThompsonWW, Shay DK,Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289(2):179-86.
2. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004;292(11):1333-1340.
3. Schanzer DL, Langley JM, Tam TW. Role of influenza and other respiratory viruses in admissions of adults to Canadian hospitals. Influenza Other Respir Viruses. 2008;2(1):1-8.
4. van Asten L, van den Wijngaard C, van Pelt W, et al. Mortality attributable to 9 common infections: significant effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza in elderly persons. J Infect Dis. 2012;206(5):628-39.
5. Brittain-Long R, Andersson LM, Olofsson S, et al. Seasonal variations of 15 respiratory agents illustrated by the application of a multiplex polymerase chain reaction assay. Scand J Infect Dis. 2012;44 (1):9-17.
6. Iwane MK, Edwards KM, Szilagyi PG, et al. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics. 2004;113(6):1758-64.
7. Weigl JA, Puppe W, Meyer CU, et al. Ten years' experience with yearround active surveillance of up to 19 respiratory pathogens in children. Eur J Pediatr. 2007;166(9):957-66.
8. Falsey AR, Erdman D, Anderson LJ, et al. Human metapneumovirus infections in young and elderly adults. J Infect Dis. 2003;187(5): 785-90.
9. Falsey AR, Hennessey PA, Formica MA, et al. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352(17):1749-59.
10. Falsey AR, Dallal GE, Formica MA, et al. Long-term care facilities: a cornucopia of viral pathogens. J Am Geriatr Soc. 2008;56(7): 1281-5.
11. Widmer K, Zhu Y,Williams JV, et al. Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. J Infect Dis. 2012;206(1):56-62.
12. Walsh EE, Shin JH, Falsey AR. Clinical impact of human coronaviruses 229E and OC43 infection in diverse adult populations. J Infect Dis. 2013;208(10):1634-42.
13. Thompson WW, Weintraub E, Dhankhar P, et al. Estimates of US influenza-associated deaths made using four different methods. Influenza Other Respir Viruses. 2009;3(1):37-49.
14. Newall AT, Viboud C, Wood JG. Influenza-attributable mortality in Australians aged more than 50 years: a comparison of different modelling approaches. Epidemiol Infect. 2010;138(6):836-42.
15. Gilca R, De Serres G, Skowronski D, et al. The need for validation of statistical methods for estimating respiratory virus-attributable hospitalization. Am J Epidemiol. 2009;170(7):925-36.
16. Yang L, Chiu SS, Chan KP, et al. Validation of statistical models for estimating hospitalization associated with influenza and other respiratory viruses. PLoS One. 2011;6(3):e17882.
17. Mangtani P, Hajat S, Kovats S, et al. The association of respiratory syncytial virus infection and influenza with emergency admissions for respiratory disease in London: an analysis of routine surveillance data. Clin Infect Dis. 2006;42(5):640-6.
18. Centers for Disease Control and Prevention. Update: influenza activity-United States, 2011-12 season and composition of the 2012-13 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2012;61 (22):414-20.
19. McNeil S, Shinde V, Andrew M, et al. Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014. Euro Surveill. 2014;19(9).
20. Ebell MH, Afonso A. A systematic review of clinical decision rules for the diagnosis of influenza. Ann Fam Med. 2011;9(1):69-77.
21. Peci A, Winter AL, Gubbay JB, et al. Community-acquired respiratory viruses and co-infection among patients of Ontario sentinel practices, April 2009 to February 2010. Influenza Other Respir Viruses. 2013;7 (4):559-66.
22. Fowlkes A, Giorgi A, Erdman D, et al. Viruses associated with acute respiratory infections and influenza-like illness among outpatients from the Influenza Incidence Surveillance Project, 2010-2011. J Infect Dis. 2014;209(11):1715-25.
23. Kaye M, Skidmore S, Osman H, et al. Surveillance of respiratory virus infections in adult hospital admissions using rapid methods. Epidemiol Infect. 2006;134(4):792-8.
24. Minosse C, Selleri M, Zaniratti MS, et al. Frequency of detection of respiratory viruses in the lower respiratory tract of hospitalized adults. J Clin Virol. 2008;42(2):215-20.
25. Johnstone J, Majumdar SR, Fox JD, et al. Viral infection in adults hospitalized with community-acquired pneumonia: prevalence, pathogens, and presentation. Chest. 2008;134(6):1141-8.
26. Walker E, Ison MG. Respiratory viral infections among hospitalized adults: experience of a single tertiary healthcare hospital. Influenza Other Respir Viruses. 2014;8(3):282-92.
27. Litwin CM, Bosley JG. Seasonality and prevalence of respiratory pathogens detected by multiplex PCR at a tertiary care medical center. Arch Virol. 2014;159(1):65-72.
28. Zhou H, Thompson WW, Viboud CG, et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis. 2012;54(10):1427-36.
29. Oughton M, Dascal A, Laporta D, et al. Evidence of viremia in 2 cases of severe pandemic influenza A H1N1/09. Diagn Microbiol Infect Dis. 2011;70(2):213-7.
30. Garbino J, Soccal PM, Aubert JD, et al. Respiratory viruses in bronchoalveolar lavage: a hospital-based cohort study in adults. Thorax. 2009;64(5):399-404.
31. Falsey AR, Becker KL, Swinburne AJ, et al. Bacterial complications of respiratory tract viral illness: a comprehensive evaluation. J Infect Dis. 2013;208(3):432-41.
32. Public Health Agency of Canada. FluWatch. http://phac-aspc.qc.ca/ fluwatch/12-13/w09_13/index-eng.php. Accessed March 22, 2013.
33. Dubuque J, Landry M, Mercier M, et al. Bilan 2012-2013: une longue saison grippale marquée par son intensité. Flash Grippe. 2013;3 (10):1-8.
34. Lee N, Choi KW, Chan PK, et al. Outcomes of adults hospitalised with severe influenza. Thorax. 2010;65(6):510-5.
35. Jhung MA, D'Mello T, Perez A, et al. Hospital-onset influenza hospitalizations- United States, 2010-2011. Am J Infect Control. 2014;42 (1):7-11.
36. Macesic N, Kotsimbos TC, Kelly P, et al. Hospital-acquired influenza in an Australian sentinel surveillance system. Med J Aust. 2013;198 (7):370-2.
37. Taylor G, Mitchell R, McGeer A, et al. Healthcare-associated influenza in Canadian hospitals from 2006 to 2012. Infect Control Hosp Epidemiol. 2014;35(2):169-75.
38. Brittain-Long R, Westin J, Olofsson S, et al. Prospective evaluation of a novel multiplex real-time PCR assay for detection of fifteen respiratory pathogens-duration of symptoms significantly affects detection rate. J Clin Virol. 2010;47(3):263-7.
39. Gadsby NJ, Hardie A, Claas EC, et al. Comparison of the Luminex Respiratory Virus Panel fast assay with in-house real-time PCR for respiratory viral infection diagnosis. J Clin Microbiol. 2010;48(6): 2213-6.
40. Thomas RE. Is influenza-like illness a useful concept and an appropriate test of influenza vaccine effectiveness? Vaccine. 2014;32(19):2143-9.